«Immunologic

Below is an extended Immunologic news listing. Click here to return to the Immunologic main in depth entry.

BioNews Results for Immunologic:
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer Pharma Live:  Oct 4 2008 1:02AM Matching: immunologic
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer Business Wire via Yahoo!:  Oct 1 2008 11:54AM Matching: immunologic
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer Genetic Engineering News:  Oct 1 2008 11:00AM Matching: immunologic
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer Earthtimes.org:  Oct 1 2008 10:44AM Matching: immunologic
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer Forbes.com:  Oct 1 2008 10:33AM Matching: immunologic
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer Calibre Macro World:  Oct 1 2008 10:16AM Matching: immunologic
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer MarketWatch:  Oct 1 2008 10:14AM Matching: immunologic
[Immunotherapy] Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloabla Journal of Clinical Oncology:  Sep 23 2008 3:52AM Matching: immunologic
IRX Therapeutics to Present Phase 2 Results at 7th International Conference on Head and Neck Cancer Pharma Live:  Jul 15 2008 4:36PM Matching: immunologic

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.